
News|Articles|January 1, 2004
ALLHAT and JNC 7: Health-system applications and economic considerations
New Orleans-The results of the Antihypertensive and Lipid-Lowering Treatmentto Prevent Heart Attack (ALLHAT) Trial, along with the highlights of theSeventh Report of the Joint National Committee on Prevention, Detection,Evaluation, and Treatment of High Blood Pressure (JNC 7), were reviewedat an educational session of the recently concluded 38th ASHP Midyear ClinicalMeeting.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Journavx helped most patients avoid opioids after surgery, a recent study found
2
The biosimilars market is projected to nearly double — here's where the growth is coming from
3
Cholinergic urticaria: Hives caused by heat and what can be done about it
4
A conversation with David Chen, Pharm.D., about balancing innovation and financial sustainability at Kaiser Permanente
5















